“ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS”, Mediterr J Hematol Infect Dis, vol. 4, no. 1, p. e2012072, Nov. 2012, doi: 10.4084/mjhid.2012.072.